{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:36:48Z","timestamp":1792255008562,"version":"4.4.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019721","name":"Roche Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019721","name":"Roche Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007509","name":"Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013298","name":"Sociedad Espa\u00f1ola de Reumatolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013298","name":"Sociedad Espa\u00f1ola de Reumatolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019721","name":"Roche Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019720","name":"GlaxoSmithKline Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019721","name":"Roche Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019721","name":"Roche Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019721","name":"Roche Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019721","name":"Roche Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019721","name":"Roche Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011218","name":"Sandoz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.reumae.2022.02.004","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T09:00:06Z","timestamp":1662454806000},"page":"443-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Jos\u00e9 Antonio","family":"Rodr\u00edguez Portal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9","family":"Brito Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"D\u00edaz del Campo Fontecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Asunci\u00f3n","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mena-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Cano-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Castellv\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Aburto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Vanesa","family":"Hern\u00e1ndez Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix Manuel","family":"Francisco Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Correyero Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Abad Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Narv\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2022.02.004_bib0005","doi-asserted-by":"crossref","first-page":"21551","DOI":"10.1038\/s41598-020-76511-6","article-title":"The prevalence of rheumatoid arthritis in Spain","volume":"10","author":"Silva-Fern\u00e1ndez","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.reumae.2022.02.004_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0039-1683995","article-title":"Pulmonary complications of rheumatoid arthritis","volume":"40","author":"Farquhar","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.rdc.2014.12.004","article-title":"Lung disease in rheumatoid arthritis","volume":"41","author":"Yunt","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.reumae.2022.02.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0011-2021","article-title":"Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.reumae.2022.02.004_bib0025","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/art.40574","article-title":"The lung in rheumatoid arthritis: focus on interstitial lung disease","volume":"70","author":"Spagnolo","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0030","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2022.02.004_bib0035","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/rheumatology\/keaa577","article-title":"Rheumatoid arthritis related interstitial lung disease \u2014 improving outcomes over 25 years: a large multicentre UK study","volume":"60","author":"Kelly","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2022.02.004_bib0040","series-title":"Elaboraci\u00f3n de Gu\u00edas de Pr\u00e1ctica Cl\u00ednica en el Sistema Nacional de Salud. Manual Metodol\u00f3gico","author":"Grupo de trabajo sobre GPC","year":"2007"},{"key":"10.1016\/j.reumae.2022.02.004_bib0045","series-title":"50: A guideline developers\u2019 handbook","author":"NHS Scotland","year":"2011"},{"key":"10.1016\/j.reumae.2022.02.004_bib0050","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2014a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2022.02.004_bib0055","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1183\/09031936.00166813","article-title":"Smoking-related idiopathic interstitial pneumonia","volume":"44","author":"Flaherty","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.reumae.2022.02.004_bib0060","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/MCP.0b013e328356803b","article-title":"Combined pulmonary fibrosis and emphysema in connective tissue disease","volume":"18","author":"Cottin","year":"2012","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ebiom.2018.01.038","article-title":"Prevalence and effects of emphysema in never-smokers with rheumatoid arthritis interstitial lung disease","volume":"28","author":"Jacob","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.reumae.2022.02.004_bib0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/annrheumdis-2020-217230","article-title":"Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)","volume":"80","author":"Spagnolo","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2022.02.004_bib0075","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s12325-020-01578-6","article-title":"Estimation of the prevalence of progressive fibrosing interstitial lung diseases: systematic literature review and data from a physician survey","volume":"38","author":"Olson","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.reumae.2022.02.004_bib0080","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.39971","article-title":"Progressive decline of lung function in rheumatoid arthritis-associated interstitial lung disease","volume":"69","author":"Zamora-Legoff","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0085","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0090","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","article-title":"Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0095","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0100","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/s10165-010-0280-z","article-title":"Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA","volume":"20","author":"Shidara","year":"2010","journal-title":"Modern Rheumatology"},{"key":"10.1016\/j.reumae.2022.02.004_bib0110","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2022.02.004_bib0115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"25","author":"Bilgici","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2022.02.004_bib0120","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/thx.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.reumae.2022.02.004_bib0125","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","article-title":"Pulmonary involvement in early rheumatoid arthritis patients","volume":"30","author":"Habib","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1756-185X.2009.01376.x","article-title":"Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease","volume":"12","author":"Mohd Noor","year":"2009","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.reumae.2022.02.004_bib0145","first-page":"1513","article-title":"Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis","volume":"35","author":"Mori","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0150","first-page":"325","article-title":"Pulmonary changes on high-resolution computed tomography of patients with rheumatoid arthritis and their association with clinical, demographic, serological and therapeutic variables","volume":"51","author":"Skare","year":"2011","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0155","doi-asserted-by":"crossref","first-page":"708","DOI":"10.12659\/MSM.890880","article-title":"A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in Chinese patients","volume":"21","author":"Wang","year":"2015","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.reumae.2022.02.004_bib0160","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10067-017-3561-5","article-title":"Retrospective study of the cl\u00ednical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease","volume":"36","author":"Zhang","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2004.02.001","article-title":"Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients","volume":"72","author":"Zrour","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.reumae.2022.02.004_bib0170","doi-asserted-by":"crossref","first-page":"15640","DOI":"10.1038\/s41598-020-72768-z","article-title":"A prospective study of lung disease in a cohort of early rheumatoid arthritis patients","volume":"10","author":"Robles-P\u00e9rez","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.reumae.2022.02.004_bib0175","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s10067-019-04846-1","article-title":"A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease","volume":"39","author":"Li","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0180","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017088","article-title":"High-resolution computed tomography of the lung in patients with rheumatoid arthritis: prevalence of interstitial lung disease involvement and determinants of abnormalities","volume":"98","author":"Salaffi","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.reumae.2022.02.004_bib0185","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.semarthrit.2020.08.015","article-title":"Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: prevalence, risk factors, and impact on mortality","volume":"50","author":"Huang","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.reumae.2022.02.004_bib0190","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1378\/chest.13-1394","article-title":"Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis","volume":"146","author":"Doyle","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.reumae.2022.02.004_bib0200","first-page":"33","article-title":"Cause of death in 81 autopsied patients with rheumatoid arthritis","volume":"21","author":"Suzuki","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0205","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00408-016-9916-x","article-title":"Association of single nucleotide polymorphisms of PADI4 and HLA-DRB1 alleles with susceptibility to rheumatoid arthritis-related lung diseases","volume":"194","author":"Song","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.reumae.2022.02.004_bib0210","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","article-title":"Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis","volume":"106","author":"Mori","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.reumae.2022.02.004_bib0220","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.1780391014","article-title":"Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities","volume":"39","author":"Saag","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2022.02.004_bib0225","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.40904","article-title":"Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study","volume":"71","author":"Sparks","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0230","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3899\/jrheum.131341","article-title":"A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity","volume":"41","author":"Zhu","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0235","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2022.02.004_bib0240","article-title":"Anti-cyclic citrullinated peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis","volume":"9","author":"Yin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.reumae.2022.02.004_bib0245","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/annrheumdis-2019-216709","article-title":"Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease","volume":"79","author":"Castellanos-Moreira","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2022.02.004_bib0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/art.38904","article-title":"Biomarkers of rheumatoid arthritis-associated interstitial lung disease","volume":"67","author":"Chen","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0255","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/03009742.2018.1477989","article-title":"Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study","volume":"48","author":"Matsuo","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0260","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","article-title":"Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers","volume":"191","author":"Doyle","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0265","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/art.37881","article-title":"Identification of citrullinated HSP90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease","volume":"65","author":"Harlow","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2022.02.004_bib0270","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0275","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02314-2016","article-title":"Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis","volume":"49","author":"Juge","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.reumae.2022.02.004_bib0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-9255-9-27","article-title":"Investigation of telomerase\/telomeres system in bone marrow mesenchymal stem cells derived from IPF and RA-UIP","volume":"9","author":"Antoniou","year":"2012","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.reumae.2022.02.004_bib0285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12890-018-0670-0","article-title":"\"Velcro-type\" crackles predict specific radiologic features of fibrotic interstitial lung disease","volume":"18","author":"Sgalla","year":"2018","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0290","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12890-019-0875-x","article-title":"Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease inrheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device)","volume":"19","author":"Manfredi","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0295","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.compbiomed.2018.03.006","article-title":"Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis","volume":"96","author":"Pancaldi","year":"2018","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0300","first-page":"344","article-title":"Patterns of interstitial lung disease and mortality in rheumatoid arthritis","volume":"56","author":"Zamora-Legoff","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2022.02.004_bib0305","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000502551","article-title":"Rheumatoid arthritis-associated interstitial lung disease: clinical characteristics and predictors of mortality","volume":"98","author":"Hyldgaard","year":"2019","journal-title":"Respiration"},{"key":"10.1016\/j.reumae.2022.02.004_bib0310","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s10067-018-4382-x","article-title":"Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population","volume":"38","author":"Fu","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0315","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.61.6.517","article-title":"Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis","volume":"61","author":"Dawson","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2022.02.004_bib0320","first-page":"216","article-title":"The value of biomarkers as predictors of outcome in patients with rheumatoid arthritis-associated usual interstitial pneumonia","volume":"33","author":"Lee","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.reumae.2022.02.004_bib0325","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1007\/s10067-019-04673-4","article-title":"A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis","volume":"38","author":"Li","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232978","article-title":"Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease","volume":"15","author":"Avouac","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.reumae.2022.02.004_bib0335","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00296-017-3781-7","article-title":"Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis","volume":"37","author":"Kim","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2022.02.004_bib0340","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2022.02.004_bib0345","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.rmed.2013.05.002","article-title":"Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD)","volume":"107","author":"Solomon","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0350","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3904\/kjim.2016.349","article-title":"Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis","volume":"34","author":"Yang","year":"2019","journal-title":"Korean J Int Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0355","first-page":"103","article-title":"Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia","volume":"30","author":"Song","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.reumae.2022.02.004_bib0360","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10067-017-3707-5","article-title":"Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis","volume":"36","author":"Rojas-Serrano","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0365","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.reumae.2022.02.004_bib0370","article-title":"Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.reumae.2022.02.004_bib0375","first-page":"1","article-title":"Related factors, increased mortality and causes of death in patients with rheumatoid arthritis-associated interstitial lung disease","author":"Kakutani","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0380","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.semarthrit.2019.04.005","article-title":"Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"49","author":"Singh","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.reumae.2022.02.004_bib0385","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.rmed.2017.03.027","article-title":"High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: relationship to survival","volume":"126","author":"Yunt","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0390","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.reumae.2022.02.004_bib0395","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.rmed.2017.11.013","article-title":"Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung disease","volume":"134","author":"Nurmi","year":"2018","journal-title":"Respiratory medicine"},{"key":"10.1016\/j.reumae.2022.02.004_bib0400","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/14397595.2018.1442170","article-title":"Radiological fibrosis score is strongly associated with worse survival in rheumatoid arthritis-related interstitial lung disease","volume":"29","author":"Ito","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0405","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00869-2018","article-title":"Predicting outcomes in rheumatoid arthritis related interstitial lung disease","volume":"53","author":"Jacob","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.reumae.2022.02.004_bib0410","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rmed.2017.04.012","article-title":"The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease","volume":"127","author":"Morisset","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0415","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12890-016-0358-2","article-title":"Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?","volume":"17","author":"Nurmi","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.reumae.2022.02.004_bib0420","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.semarthrit.2020.07.011","article-title":"Risk of interstitial lung disease in patients with newly diagnosed systemic autoimmune rheumatic disease: a nationwide, population-based cohort study","volume":"50","author":"Ng","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.reumae.2022.02.004_bib0425","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/rheumatology\/kez177","article-title":"The lung in a cohort of rheumatoid arthritis patients-an overview of different types of involvement and treatment","volume":"58","author":"Duarte","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2022.02.004_bib0430","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10067-009-1128-9","article-title":"Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA","volume":"28","author":"Gizinski","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2022.02.004_bib0435","doi-asserted-by":"crossref","first-page":"342","DOI":"10.12691\/ajmcr-7-12-10","article-title":"Interstitial lung disease as the initial manifestation of rheumatoid arthritis: a case report and review of the literature","volume":"7","author":"Singh","year":"2019","journal-title":"Am J Med Case Rep"},{"key":"10.1016\/j.reumae.2022.02.004_bib0440","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/resp.12234","article-title":"Predictors of mortality in rheumatoid arthritis-related interstitial lung disease","volume":"19","author":"Assayag","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.reumae.2022.02.004_bib0445","article-title":"Criterios de cribado de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide: propuesta de expertos basada en metodolog\u00eda Delphi","author":"Narv\u00e1ez","year":"2022","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reumae.2022.02.004_bib0450","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"50","author":"Raghu","year":"2017","journal-title":"Eur Respir J"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574322001265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574322001265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:02:21Z","timestamp":1761879741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574322001265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":90,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2173574322001265"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2022.02.004","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2022.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2022.02.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}